The initiative aims to increase biomarker testing rates in communities most impacted by lung cancer disparities. Learn what the global survey showed about the rates of biomarker testing and the remaining barriers to implementation. The registry, launched by the Florez Lab in 2023, is collecting data from around the world. Indoor air pollutants can come from multiple sources and can be risk factors for developing lung cancer. Annette McWilliams, MBBS, FRACP, PhD, discusses her IASLC Presidential Symposium presentation on the study. Eric Singhi, MD, discusses the key milestone that will be celebrated at the conference, which will be held in San Diego. The study aims to build a comprehensive, open-source database of heritable genetics and patient-reported data in lung cancer.